Trials / Completed
CompletedNCT00643149
A Multicenter, Randomized, Double-Blind, Double-Dummy Study Of Azithromycin SR Versus Amoxicillin For The Treatment Of Strep Throat In Children
A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial Of Azithromycin SR Versus Amoxicillin For The Treatment Of Group A Β-Hemolytic Streptococcal Pharyngitis/Tonsillitis In Children
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 693 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 2 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The objective was to determine if a single 60 mg/kg dose of azithromycin SR was as safe and effective as a 10-day regimen of amoxicillin (45 mg/kg/day, given in divided doses every 12 hours) when used to treat children with strep throat.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | amoxicillin | 10 day regimen, 45 mg/kg/day, given in divided doses every 12 hours |
| DRUG | azithromycin SR | 60 mg/kg dose of azithromycin SR was as safe and effective as a 10-day regimen of amoxicillin when used to treat children with strep throat |
Timeline
- Start date
- 2003-05-01
- Completion
- 2004-03-01
- First posted
- 2008-03-26
- Last updated
- 2011-05-17
Locations
46 sites across 5 countries: United States, Canada, Costa Rica, Guatemala, India
Source: ClinicalTrials.gov record NCT00643149. Inclusion in this directory is not an endorsement.